Question 1

Does Citigroup own PRAX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Citigroup holds 23,599 shares of PRAX (Praxis Precision Medicines), worth $7.9M.

Question 2

How many shares of PRAX does Citigroup own?

Accepted Answer

As of its Q2 2026 13F, Citigroup holds 23,599 shares of PRAX (Praxis Precision Medicines).

Question 3

What is Citigroup's PRAX position worth?

Accepted Answer

As of its Q2 2026 13F, Citigroup's PRAX position is worth $7.9M.

Question 4

Is Citigroup buying or selling PRAX?

Accepted Answer

In Q2 2026, Citigroup increased its PRAX position from 5,646 to 23,599 shares.

Question 5

When did Citigroup first buy PRAX?

Accepted Answer

Citigroup already held PRAX in its Q4 2023 13F, the earliest on record, and has listed it in 11 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	23,599	+318.0%	$7.9M	0.0%	$334.79	44
2026-Q1	Increased	5,646	+1.1%	$1.8M	0.0%	$318.22	26
2025-Q4	Increased	5,586	+99.0%	$1.6M	0.0%	$297.02	41
2025-Q3	Decreased	2,807	-76.3%	$148,771	0.0%	$52.38	0
2025-Q2	Decreased	11,866	-74.0%	$498,965	0.0%	$43.00	0
2025-Q1	Decreased	45,632	-52.0%	$1.7M	0.0%	$38.66	0
2024-Q4	Increased	95,047	+14.0%	$7.3M	0.0%	$76.96	31
2024-Q3	Increased	83,350	+995.1%	$4.8M	0.0%	$57.54	43